Prof. Yong Li 李勇
Chief Physician, Professor
Department of Thoracic Surgery, Cancer Hospital, Chinese Academy of Medical Sciences (National Cancer Center), Beijing
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and treatment of lung, esophageal, cardia, and mediastinal tumors. Specializes in minimally invasive thoracoscopic surgery and complex or reoperative cases.
Dr. Li holds an MD and serves as Chief Physician at the Cancer Hospital, Chinese Academy of Medical Sciences. Previously worked at Hebei Medical University Fourth Hospital. Trained in Japan and the US (Duke, Methodist, Jackson Memorial). Focuses on minimally invasive techniques, multidisciplinary care, and clinical research. Holds over 30 patents and has published nearly 100 papers.
Professional roles
- Member, Chinese Medical Association Thoracic and Cardiovascular Surgery Branch Esophageal Cancer Group
- Vice Chair and Secretary-General, China Anti-Cancer Association Integrated Esophageal Cancer Committee
- Secretary-General and Member, China Anti-Cancer Association Esophageal Cancer Professional Committee
- Standing Committee Member, Cross-Strait Medical and Health Exchange Association Thoracic Surgery Professional Committee
Name order: in Chinese the family name comes first (Li Yong). Papers usually list the name as Yong Li or Li Y.
Selected publications
84 papers on PubMed matched by name and affiliation; 19 as first or senior author since 2016. Most recent first- or senior-author papers:
- J Adv Res, 2026 (senior author): Development and multicenter validation of a cfDNA methylation-based PCR assay (myESCAP) with machine-learning prediction for non-invasive detection of esophageal cancer. PubMed 42962916
- Thorac Cancer, 2026 (senior author): Cervical Anastomotic Leakage After Minimally Invasive McKeown Esophagectomy in the SAFER Surgical System: Clinical Course and Predictors of Delayed Healing. PubMed 42267628
- J Thorac Dis, 2026 (senior author): Machine learning to predict distant metastasis risk and prognostic analysis in T1-2 esophageal cancer: a study based on the SEER database. PubMed 42306722
- Front Immunol, 2026 (senior author): Efficacy and safety of neoadjuvant immunotherapy in locally advanced resectable esophageal squamous cell carcinoma: a network meta-analysis and real-world study. PubMed 41836437
- Colloids Surf B Biointerfaces, 2026 (senior author): Circulating catalysis nanocomposites for photodynamic and starvation treatment via long-persistent regulation of tumor hypoxia. PubMed 41176852
- J Thorac Dis, 2025 (senior author): Prognostic value of left gastric artery lymph node metastasis in patients with thoracic esophageal squamous cell carcinoma: a retrospective cohort study. PubMed 41522127
- Dis Esophagus, 2025 (senior author): Prognostic impact of recurrent laryngeal nerve lymph node metastatic status in thoracic esophageal squamous cell carcinoma. PubMed 40542790
- Ann Surg Oncol, 2025 (senior author): Outcomes of Intraoperative Radiotherapy for Locally Advanced Adenocarcinoma of the Esophagogastric Junction After Neoadjuvant Therapy: A Single-Arm, Phase 1 Trial From the Chinese National Cancer Center. PubMed 39648241
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion